SciRhom
Martinsried, DE · 3 known investors
SciRhom is a biotech company developing first-in-class humanized antibodies against iRhom2, which regulates the enzyme TACE/ADAM17 to block pro-inflammatory signaling pathways. Its pipeline targets autoimmune diseases including rheumatoid arthritis, inflammatory bowel disease, and lupus nephritis.
BiotechDeep TechHealthtech
Founders & leadership
DJ
Dr. Jens RuheCo-founder, Managing Director & Chief Operating Officer
DM
Dr. Matthias SchneiderCo-founder & Chief Scientific Officer
DJ
Dr. Jan PothManaging Director, Chief Executive Officer
DJ
Dr. Jürgen ReeßChief Medical Officer
Investors · 3
In the news
Frequently asked questions
- What does SciRhom do?
- SciRhom is a biotech company developing first-in-class humanized antibodies against iRhom2, which regulates the enzyme TACE/ADAM17 to block pro-inflammatory signaling pathways. Its pipeline targets autoimmune diseases including rheumatoid arthritis, inflammatory bowel disease, and lupus nephritis.
- Who founded SciRhom?
- SciRhom was founded by Dr. Jens Ruhe, Dr. Matthias Schneider.
- Who are SciRhom's investors?
- SciRhom's investors include Andera Partners, Hadean Ventures, Kurma Partners.
- Where is SciRhom headquartered?
- SciRhom is headquartered in Martinsried, DE.